Provider of skin cancer screening services designed to detect and manage skin cancer risk. DermaScan is based in Paris, France. Its last reported valuation was $950,000 in Dec 2024. It has raised $2.8 million.
Last reported valuation
$950K
Oct 2026
Priced at
—
Total raised
$2.8M
Last round
—
Team — not yet on record
No current team members for DermaScan are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of DermaScan with a free account
·Watch DermaScan: the Monday email on marks, rounds and moves
